MedTrace Logo

Injection Technique Assessment of Restylane Lyft With Lidocaine for Cheek Augmentation

NCT03160716 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-08-26

Study results available
· View outcomes & findings →

Summary

This is a multi-center, open-label, single-arm study to evaluate an injection tool with Restylane Lyft with Lidocaine for cheek augmentation and correction of age related midface contour deficiencies.

Conditions

  • Cheek Augmentation
  • Midface Contour Deficiencies

Interventions

DEVICE

Restylane Lyft with Lidocaine

a sterile gel of hyaluronic acid (HA)

Sponsors & Collaborators

  • Galderma R&D

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-16
Primary Completion
2017-10-31
Completion
2017-10-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03160716 on ClinicalTrials.gov